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The DNA abnormality found in 98% of Friedreich’s ataxia (FRDA)
patients is the unstable hyperexpansion of a GAATTC triplet
repeat in the first intron of the frataxin gene. Expanded GAATTC
repeats result in decreased transcription and reduced levels of
frataxin protein in affected individuals. -Alanine-linked pyrrole–
imidazole polyamides bind GAATTC tracts with high affinity and
disrupt the intramolecular DNADNA-associated region of the
sticky-DNA conformation formed by long GAATTC repeats. Fluo-
rescent polyamide-Bodipy conjugates localize in the nucleus of a
lymphoid cell line derived from a FRDA patient. The synthetic
ligands increase transcription of the frataxin gene in cell culture,
resulting in increased levels of frataxin protein. DNA microarray
analyses indicate that a limited number of genes are significantly
affected in FRDA cells. Polyamides may increase transcription by
altering the DNA conformation of genes harboring long GAATTC
repeats or by chromatin opening.
gene regulation  triplet repeat expansion  frataxin
The neurodegenerative disease Friedreich’s ataxia (FRDA) iscaused by hyperexpansion of GAATTC repeats in the first
intron of a nuclear gene that encodes the essential mitochondrial
protein frataxin (1–4). Normal frataxin alleles have 6–34 repeats,
whereas FRDA patient alleles have 66–1,700 repeats. Intronic
GAATTC repeats interfere with gene transcription (5–7). Longer
repeats cause a more profound frataxin deficiency and are associ-
ated with earlier onset and increased severity of the disease (4).
Biochemical studies have documented that expanded GAATTC
repeats adopt unusual non-B DNA structures, such as triplexes,
containing two purine GAA strands along with one pyrimidine
TTC strand, flanking a single-stranded pyrimidine region (5, 8) as
well as intramolecular ‘‘sticky’’ DNA (6, 9–12). Long (GAATTC)n
repeat sequences form sticky DNA with two separate long
(GAATTC)n repeating tracts associated within a single closed
plasmidDNA. The interaction of the two tracts requires the repeats
oriented in the direct repeat orientation, negative supercoiling and
the presence of divalent metal ions to stabilize the DNADNA-
associated region (8–10). We have demonstrated the capacity of
sticky DNA to form both in vitro (10, 13) and in vivo (11–13).
Triplexes andor stickyDNAblock elongation byRNApolymerase
II (5). Another study using artificial transgenes has shown that
expandedGAATTC repeats induce repressive heterochromatin in
vivo in a manner reminiscent of position-effect variegation (14).
This effect was augmented by coexpression of heterochromatin
protein 1. Here, we address whether minor-groove DNA-binding
small molecules can alleviate transcription repression of the
frataxin gene.
Molecules that reverse triplexsticky DNA andor heterochro-
matin formation in the frataxin gene may increase successful
elongation through expandedGAATTC repeats, thereby relieving
the deficiency in frataxinmRNAand protein in FRDAcells (11, 14,
15). Pyrrole–imidazole polyamides are cell-permeable small mol-
ecules that can be programmed to recognize a broad repertoire of
DNA sequences (16). Two classes of polyamides are well estab-
lished: hairpin polyamides bind mixed-sequence DNA with high
affinity and specificity (16, 17), and linear -alanine-linked poly-
amides are available for targeting purine tracts of DNA, such as
GAGAATTCTC repeats (18, 19). -Alanine-linked polyamides
have been shown to bind GAGAA repeats in Drosophila satellite
DNA both in vitro and in cytological chromosome spreads (19).
These molecules induce chromatin opening and reverse hetero-
chromatin-mediated position-effect gene silencing when adminis-
tered to Drosophila embryos (19, 20).
Structural studies indicate that -alanine-linked polyamides bind
the minor groove of canonical B DNA (21). Given the high affinity
of -alanine-linked polyamides for purine tracts (18), these mole-
cules might act as a thermodynamic ‘‘sink’’ and lock GAATTC
repeats into double-stranded BDNA. Such an event would disfavor
duplex unpairing, which is necessary for formation of FRDA
triplexes and stickyDNA.Although single polyamides boundwithin
coding regions of genes do not appear to block transcription
elongation (22–24), we cannot be certain that multiple polyamides
have the potential to relieve transcription repression at expanded
GAATTC repeats. Alternatively, polyamides may relieve hetero-
chromatin-mediated repression by opening the chromatin domain
containing the frataxin gene (20).
Results and Discussion
Targeting GAATTC Repeat DNA with High-Affinity Ligands. We syn-
thesized two -alanine-linked polyamides of different length, FA1
(ImPyImPyImDp, where Py is pyrrole, Im is imidazole,  is
-alanine, andDp is dimethylaminopropylamine) to target the 9-bp
site 5-AAGAAGAAG-3 and FA3 (ImPyImPyImPyImDp)
to target the 12-bp site 5-AAGAAGAAGAAG-3 (Fig. 1A).
Quantitative DNase I footprinting (25) demonstrates that FA1
binds to a radiolabeled PCR product containing a (GAATTC)6
sequence with an apparent dissociation constant (Kd) of 0.1 nM
(Fig. 2A and Table 1). FA3 exhibits aKd of3 pM in footprinting
experiments performed at low DNA concentrations (Fig. 6A,
which is published as supporting information on the PNAS web
site, and Table 1); however, this valuemay be an underestimation
of the affinity of this molecule for GAATTC repeat DNA,
because our Kd measurements are limited by a minimum DNA
concentration of 2 pM in the binding reaction. Two mismatch
controls, FA2 (ImPyImImPyDp) (Fig. 1A) and FA4
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(ImPyImPyImImPyDp), have binding affinities for the
(GAATTC)6 target sequence that are three orders of magni-
tude lower than those of the match polyamides (Figs. 2B and 6B
and Table 1). FA1 is also able to bind extended regions of
GAATTC repeats [(GAATTC)33] with no loss in affinity, with
several molecules of FA1 bound per DNA molecule (Fig. 7,
which is published as supporting information on the PNAS web
site). As another test for sequence specificity, footprinting
experiments with FA1 and FA3 and a radiolabeled DNA frag-
ment containing a mismatch DNA sequence (5-. . . AGGAG-
GAGGTGGAGGAGGA. . . -3) were performed. Neither FA1
nor FA3 bound this DNA sequence at polyamide concentrations
up to 100 nM (Fig. 8, which is published as supporting infor-
mation on the PNASweb site). FA1 binds other polypurine DNA
tracts with single G-to-A transitions, maintaining similar or
slightly reduced binding affinities compared with the 5-
AAGAAGAAG-3 site. A sequence harboring two transitions
(A-to-G and G-to-A), giving rise to 5-AAAAGGAAG-3,
increases the Kd of FA1 by more than three orders of magnitude.
Truncation of FA1 to ImPyImDp increases its Kd on 5-
AAGAAGAAG-3 by more than four orders of magnitude
(P.B.D. and J.W.P., unpublished data).
Nuclear Localization of Fluorescent Polyamides. Fluorescent versions
of the match polyamides FA1 and FA3 and mismatch polyamide
FA2 were synthesized, where the dye Bodipy FL (C5) was attached
at the carboxyl terminus of the polyamide (Fig. 1A). Quantitative
DNase I footprinting demonstrated that polyamides FA1- and
FA3-Bodipy exhibit 13- to 20-fold losses in binding affinity for
(GAATTC)6 DNA, compared with the parent polyamides (for
FA1-Bodipy,Kd 1.3 nM) (Fig. 9, which is published as supporting
information on the PNASweb site; for FA3-Bodipy,Kd 0.04 nM).
Epstein–Barr virus-transformed lymphoblast cell lines from an
FRDApatient (lineGM15850) and froman unaffected sibling (line
GM15851) were obtained from the NIGMS Human Genetic Cell
Repository (Coriell Institute, Camden, NJ). Both the match FA1-
Bodipy and mismatch FA2-Bodipy conjugates localize in the nu-
Fig. 1. Polyamide structures, binding models, and nuclear localization in cell culture. (A) Structures of polyamides FA1, FA2, FA3, and FA4 (R, methyl) and their
Bodipy conjugates (R, N-propylbutanamide-linked Bodipy FL). Polyamide structures are represented schematically as binding models. Filled and open circles are
Im and Py rings, respectively; diamonds are -alanine; and the semicircle with plus sign is dimethylaminopropylamine. Linear polyamides bind in a carboxyl-
to-amino-terminal orientation with respect to the 5-to-3 sequence of their DNA target site (18). Mismatches formed with polyamides FA2 and FA4 are indicated
with shaded boxes. (B) Deconvolution microscopy of unfixed lymphoid cells (GM15850, derived from an FRDA patient, and GM15851, derived from a healthy
sibling) incubated with Bodipy conjugates of each of the indicated polyamides at 2M concentration in culture medium for 16 h before visualization, as described
(44). (Scale bars, 10 m.)
Fig. 2. DNA-binding properties of the polyamides. Quantitative DNase I
footprint analysis for polyamide binding to a radiolabeled PCR product con-
taining a (GAATTC)6 repeat sequence, labeled on the purine strand. DNA (at
20 pM) and polyamide were allowed to equilibrate for 16 h, with the
indicated ranges of polyamide concentrations, before DNase digestion and
gel analysis (25). The PhosphorImage of each gel is shown, with undigested
DNA in the lane marked ‘‘’’; a GA sequencing reaction of the same DNA is
shown, along with DNase-treated DNA in the absence of polyamide (in the
lane marked ‘‘0’’). (A) FA1 targeting 5-AAGAAGAAG-3. (B) FA2, mismatch
control for FA1. An excerpt of the DNA sequence cloned in pCR2.1 DNA, used
to generate the PCR product for footprinting reactions is referenced between
A and B.
Table 1. Polyamides designed to target GAATTC repeats in the
frataxin gene
Polyamide sequence
(GAATTC)n
repeat no. in
target site, n
Binding
affinity
(Kd, nM)*
FA1: ImPyImPyImDp 3 0.11  0.02
FA2: ImPyImImPyDp 3 100
FA3: ImPyImPyImPyImDp 4 0.003  0.001
FA4: ImPyImPyImImPyDp 4 2.0  0.4
Mismatch amino acids are underlined. Im, imidazole; Py, pyrrole; ,
-alanine; Dp, dimethylaminopropylamine.
*Binding affinities (mean values of the Kd from a minimum of two determi-
nations, and standard deviations) determined by quantitative DNase I foot-
printing, as in Fig. 2.
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cleus of live, unfixed normal and FRDA lymphoid cells after 16-h
incubation in culture medium, as determined by deconvolution
microscopy (Fig. 1B). The Bodipy-conjugate of the longer poly-
amide FA3 also localizes in the nucleus of the FRDA cells.
GAATTC-Specific Polyamides Increase Frataxin mRNA and Protein. To
assess whether polyamides alleviate transcription inhibition caused
by expanded GAATTC repeats in the frataxin gene, we used
real-time quantitative (q)RT-PCR to monitor frataxin mRNA
levels in the lymphoid cell lines described above, with the levels of
GAPDH mRNA as an internal control for each RNA sample. No
differences in GAPDHmRNA levels were found between the two
cell lines. As expected, the FRDA cell line had a markedly lower
level of frataxin mRNA compared with the cell line from the
normal individual (Fig. 3A; 13 6%, for 20 determinations, Table
2, which is published as supporting information on the PNAS web
site). We incubated the FRDA and control cells with various
concentrations of each of the polyamides for various lengths of time
and found that only polyamide FA1 increased frataxin mRNA
levels after 7-days incubation in culture medium. No changes in
frataxin mRNA levels were observed on shorter incubation times.
Over the concentrations of 1–8M,we find that polyamides are not
cytotoxic to the lymphoid cell lines (as determined by trypan blue
exclusion and measurements of ATP levels) and do not affect cell
growth rates. Importantly, the level of frataxin mRNA in the
FRDAGM15850 cell line was increased 2.5-fold by incubation with
polyamide FA1 (at 2 M, Fig. 3A). The average fold increase
observed with 2 M FA1 in the FRDA cell line is 2.2  0.6 (in 20
experiments), resulting in an average of 27% of the level of
frataxin mRNA found in the normal cell line (Table 2). We note
that polyamide concentrations greater than the Kd for in vitro
binding are required for increasing frataxin transcription, presum-
ably because of the large number of potential polyamide-binding
sites in the human genome and availability of these sites in the cell
nucleus. Despite the fact that FA1 binds the 9-bp 5-AAGAA-
GAAG-3 repeat with high affinity, the sequence landscape of all
possible high-affinity sites for this class of -linked oligomers has
not yet been fully characterized (26). Neither higher concentrations
of FA1 nor longer incubation times increased frataxin transcription
above the levels observed at 2 Mon 7-day incubations. Polyamide
FA1 did not increase frataxin mRNA levels in the cell line derived
from the normal individual. Similar incubations with the mismatch
polyamide FA2 were without significant effect in either cell line.
The levels of GAPDH mRNA were not changed by polyamide
treatment in either cell line.
We next examined the effect of removal of polyamide FA1 from
the culture medium on frataxin transcription. After induction of
frataxin mRNA synthesis by FA1 (7 days at 2 M), transfer of the
cells to fresh medium lacking polyamide caused frataxin mRNA
levels to decrease to their original levels after 96 h (data not shown).
Thus, polyamides must be continuously present to maintain active
transcription of FRDA frataxin alleles. The finding that incubation
periods of 7 days or more are necessary to observe increases in
frataxin mRNA suggests that multiple rounds of DNA replication
are necessary for the compound to alter either the DNA or
chromatin structure of expanded frataxin alleles, leading to active
transcription, and removal of the polyamide causes the frataxin
gene to readopt its inactive DNA or chromatin conformation. To
test whether cellular proliferation is required for frataxin gene
activation, we serum-starved FRDA and control cells, leading to
cell cycle arrest (confirmed by fluorescence activated cell sorting,
data not shown), and then incubated the arrested cells with
polyamide FA1 for 7 days before qRT-PCR analysis. We find no
increase in frataxin mRNA with polyamide FA1 under these
conditions, suggesting that cell division is a requirement for up-
regulation of transcription by the polyamide.
It was curious that the highest-affinity compound, FA3, did not
increase frataxin mRNA levels, because the fluorescent version of
this molecule localized in the nucleus of FRDA lymphoid cells.
Previous studies have established that nuclear localization is sen-
sitive to polyamide composition and structure and, especially, the
nature of the carboxyl terminus (27, 28); therefore, the nonfluo-
rescent version of FA3 may not enter the nucleus. To test this
hypothesis, we monitored the levels of frataxin mRNA after
incubation with FA3-Bodipy, and found an 2- to 3-fold increase
in relative levels of frataxinmRNA (comparedwithGAPDH) after
2- to 4-day incubations (data not shown). Thus, FA3 may not have
the optimum chemical properties for nuclear localization or DNA
binding in the context of cellular chromatin. In contrast, FA1-
Bodipy did not increase frataxin mRNA levels in experiments
where positive effects were found with FA1.
Because the primary transcripts from FRDA frataxin genes
contain long stretches of GAA repeat RNA sequence, it is con-
ceivable that this RNA will not be correctly processed into mature
frataxin mRNA, and frataxin protein will not be produced. To test
whether polyamide FA1 leads to increased levels of frataxin protein
in treated lymphoid cells, total-cell extracts from polyamide-treated
(1–2 M for 7 days), and untreated GM15851 control and
GM15850 FRDA cells were subjected to SDSPAGE and the
corresponding blots probed with anti-frataxin or anti-actin anti-
bodies (Fig. 3B). An 2- to 3-fold increase in frataxin protein is
observed with FA1 in the FRDA cells, which correlates well with
the observed increase in frataxin mRNA (Fig. 3A).
Effects of Polyamides on Global Gene Expression. DNA microarray
analyses were performed with RNA isolated from GM15850
FRDA and GM15851 normal lymphoid cells that were either
untreated or treated with polyamides FA1 (at 1 and 2 M) or FA2
(at 2 M) for 7 days on Affymetrix Human Genome U133 Plus 2.0
GeneChips. FA1 was found to affect the mRNA levels for a limited
number of genes in the FRDA cell line (at P  0.005, 51 genes
Fig. 3. Polyamide FA1 increases the levels of frataxin mRNA and protein in
an FRDA lymphoid cell line. (A) Measurement of frataxin mRNA levels, relative
to that of GAPDH, in cell lines derived from an unaffected individual
(GM15851) and an FRDA patient (GM15850) by qRT-PCR (44). Polyamides FA1
and FA2 were included in the cell culture medium at the indicated concen-
trations, and frataxin and GAPDH mRNA were determined after 7 days, with
media and polyamide replenished on days 3 and 5. Error bars are derived from
the percent error of the average and standard deviation of the change in cycle
threshold between frataxin and GAPDH for triplicate experiments, with trip-
licate qRT-PCR determinations for each experiment. (B) Effects of polyamides
on frataxin protein in cultured lymphoid cells. FRDA or control cells were
incubated as in A before Western blot analysis with antibody to human
frataxin or actin. Equivalent amounts of total-cell-extract protein were loaded
in each lane.
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affected by 1 M FA1, 16 genes affected by 2 M FA1) (Table 3,
which is published as supporting information on the PNAS web
site), and only 2 genes in the normal cell line (Table 3). Although
more genes were called affected by FA1 at 1 M than at 2 M, this
difference is largely due to genes whose mRNA levels change by
25% in either direction. At 2 MFA1, 15 genes were increased
in expression by50%, and 1 gene was decreased by 45%.At 1M
FA1, only 3 genes had comparable changes in their mRNA levels.
For GM15851 cells, 2 genes were up-regulated by FA1, and no
genes were down-regulated. For the frataxin gene, untreated
GM15850 cells showed 17% of the frataxin mRNA found in
untreated GM15851 cells, and incubation with FA1 at 2 M
increases frataxin mRNA by 2.5-fold, bringing the frataxin mRNA
level in GM15850 cells to 42% of that found in GM15851 cells.
These values are comparable with those obtained by qRT-PCR
(Fig. 3A). Transcript levels for frataxin were not changed by FA2
in either cell line, and FA2 affected only a small number of genes
in either cell line (at P  0.005, 3 genes affected by 2 M FA2 in
GM15850 cells, and 1 gene affected in GM15851 cells) (Table 3).
To examine the overall changes in gene-expression profiles in
treated and untreated populations of FRDA and control cells, we
first determined the genes whose expression was called significantly
different among all conditions of untreated and treated GM15851
and GM15850 cells. At a P value of 0.005, this class comparison
generated a total of 632 genes. We then generated a correlation
graph of the difference in geometric means of intensities for these
genes between untreated and treated cells for each experimental
condition (Fig. 4). Neither the match FA1 nor mismatch FA2
polyamide affected the profile of GM15851 cells (slope of the
correlation between conditions  0.04 to 0.04, Fig. 4 A–D),
whereas FA1-treated GM15850 FRDA cells (at 2 M) have a
gene-expression profile that approaches that of untreated
GM15851 cells compared with untreated FRDA cells (Fig. 4,
compareG with E; slope 0.69 compared with 0.97, respectively).
This effect is seen to a lesser degree at 1MFA1 (Fig. 4F), but was
not seen with the mismatch polyamide FA2 (Fig. 4H). These
changes in gene expression in the affected cell line may be a
consequence of changes in frataxin protein levels (29, 30), or some
could be direct effects of the polyamide, as suggested by the
occurrence of FA1 binding sites in up-regulated genes (Table 2).
Taken together, these data lead us to conclude that polyamide FA1
increases frataxin gene expression and, perhaps, downstream tar-
gets of frataxin, but thismolecule has a limited effect on global gene
expression. A search of the GenBank database reveals that most
regions of the GAATTCDNA sequence [(GAATTC)6 or longer]
are present in nontranscribed repetitive DNA elements (including
Alu sequences) in the human genome (31). Polyamide FA1 has no
effects on lymphoid cell morphology, metabolism, or growth in
culture.
Influence of Polyamides on Sticky-DNA Conformation.The capacity of
sequence-specific polyamides to disrupt the intramolecular sticky-
DNA structure formed by GAATTC repeat tracts was investi-
gated. Plasmids harboring the sticky-DNA structure are visualized
by gel electrophoresis after restriction endonuclease cleavage (Fig.
5A). Linear DNA is indicative of disruption of the sticky-DNA
structure by a polyamide, whereas the cleaved sticky-DNA band
that migrates with a much slower mobility reveals no influence of
the ligand. Plasmid pRW4886, which contains two tracts of
(GAATTC)176 in a direct-repeat orientation (10), was incubated
with each of the polyamides FA1, FA2, FA3, and FA4 at concen-
trations ranging from 0 to 50 M. The polyamide-bound DNA was
then digested with EcoNI and electrophoresed on 1% agarose gels
to determine the amount of the EcoNI-cleaved sticky-DNA-
retarded band present (Fig. 5B). Incubation of pRW4886 DNA
with FA3 shifted the equilibrium fromamaximumamount of sticky
DNA to a complete loss of the EcoNI-cleaved sticky-DNA-
retarded band at a concentration of 50 nM. FA4, which is a
mismatch of FA3 and has a Kd value1,000 times higher than FA3
(Table 1), did not affect the stability of sticky DNA in pRW4886
until an FA4 concentration of 5 M. For FA1, a 1 M concentra-
tion was needed to dissociate the DNADNA structure-forming
Fig. 4. Microarray analysis of polyamide effects on global gene expression. Correlation of significant genes called from a class comparison of all arrays (n 
632 genes at P 0.005). Cells were cultured with and without the addition of FA1 at 1 M or 2 M or FA2 at 2 M for 7 days before RNA extraction. Each graph
represents the difference between the geometric mean of intensities (from an average of the logged robust multichip average data for each condition) (47) of
untreated GM15851 cells (denoted 851 in the graphs) and untreated GM15850 cells (denoted 850) plotted versus the difference between the average from all
GM15851 geometric means of intensities and each of the individual cell types and conditions. Thus, the untreated controls for GM15851 and GM15850 cells should
give slopes for the least-squares-fit line approaching 0 and 1, respectively. Graphs for normal GM15851 cells are shown for the untreated control (A) and cells
treated with FA1 at 1 M (B) and 2 M (C) and FA2 at 2 M (D). Graphs for FRDA GM15850 cells are shown for the untreated control (E) and cells treated with
FA1 at 1 M (F) and 2 M (G) and FA2 at 2 M (H).
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region. The mismatched polyamide FA2, having the highest Kd
value of all of the polyamides tested, showed no effect on sticky-
DNA stability, even at a 100 M concentration. Thus, the binding
affinities of the polyamides for the GAATTC sequence had an
intimate relationship with the concentration needed to shift the
equilibrium from theDNADNA-associated structure to the duplex
conformation (Fig. 5B). The absence of the EcoNI-cleaved sticky-
DNA-retarded band demonstrated the capacity of the sequence-
specific polyamide binding to shift the non-B–B-DNA equilibrium
toward a conventional DNA duplex conformation in supercoiled
plasmids. Because sticky DNA inhibits transcription (5, 32), and
because the polyamides destabilize this conformation by shifting the
structural equilibrium to duplex B DNA, increases in frataxin
mRNA observed with polyamide FA1may be due to this structural
transition, although other mechanisms, such as heterochromatin
desilencing, must be considered (19).
Conclusions
Increased frataxin transcription with GAATTC-specific poly-
amides may be due to a change in DNA structure, as suggested by
reversal of sticky DNA, which then allows for transcription through
expanded GAATTC-repeat DNA, or by reversing heterochroma-
tin caused by expanded GAATTC repeats (14). Polyamides de-
signed to target the related sequence GAGAATTCTC repeat
DNA, which is found in Drosophila satellite V, have been shown to
alter gene expression in developing embryos by opening the chro-
matin domains containing these repeated sequences (14, 19) and to
displace heterochromatin protein 1 (HP1) and the other chromo-
somal proteins D1 and topoisomerase II (33). Interestingly, in the
transgene study reported by Festenstein and colleagues (14), HP1
was found to promote gene silencing by expanded GAATTC-
repeat DNA. Thus, polyamides targeting GAATTC-repeat DNA
may increase transcription of genes that harbor these sequences by
displacement of similar repressor proteins and reversal of inactive
heterochromatin to a more active chromatin structure.
Materials and Methods
Polyamide Synthesis and Characterization. Polyamides were synthe-
sized by solid-phase methods (18, 34) and their identity and purity
verified by MALDI-TOF MS and analytical HPLC. Fluorescent
conjugates were prepared by coupling Bodipy FL C5 (Molecular
Probes) to the carboxyl terminus (27). Binding affinities for match
and mismatch sites were determined by quantitative DNase I
footprinting (25). A plasmid harboring six GAATTC repeats was
constructed by cloning the oligonucleotide 5-GCCTTACGGT-
TACACTTGATGAAGAAGAAGAAGAAGAATTCGCAA-
TGCCATTGCGCTATGA-33-ACGGAATGCCAATGTG-
AACTACTTCTTCTTCTTCTTCTTAAGCGTTACGGTA-
ACGCGATAC-5 in the pCR2.1 TOPO vector (Invitrogen), and a
251-bp singly end-labeled PCR product was generated from this
plasmid with the following oligonucleotides: 5-GAAAGAC-
CCGTGTGTAAAGCC-3 and 5-CTCGATATCTGCAGAAT-
TGCC-3, where the second oligonucleotide was labeled with
-[32]ATP and polynucleotide kinase, by using standard proce-
dures, to generate a PCR product labeled on the GAA strand. A
204-bp singly end-labeled PCR product was derived from plasmid
pMP142 DNA, containing 33 GAATTC repeats (5), with the
following oligonucleotides: 5-GGCCAACATGGTGAAACC-3
and 5-GTAGCTGGGATTACAGGCGC-3. The first oligonucle-
otide shown was radiolabeled as above to generate a PCR product
labeled on the GAA strand. A 150-bp PCR product containing a
(GGATCC)3 mismatch sequence was derived from the erbB2
(Her2-neu) promoter in human genomic DNA with the following
oligonucleotides: 5-CTTGTTGGAATGCAGTTGGA-3 and 5-
GGTTTCTCCGGTCCCAAT-3, with the first oligonucleotide
radiolabeled.
Cell Culture. Epstein–Barr virus-transformed lymphoblast cell lines
GM15850 from a FRDA patient (alleles with 650 and 1,030
GAATTC repeats in the frataxin gene, from the Coriell Cell
Repository) and GM15851 from an unaffected sibling (normal
range of repeats) were propagated in RPMI medium 1640 with 2
mML-glutamine and 15%FBS at 37°C in 5%CO2. Cell growth and
morphology were monitored by phase-contrast microscopy and
viability by trypan blue exclusion and anATP assay (ApoSENSOR;
BioVision). Polyamides were added directly to the culture medium
in PBS, and incubations were for the times indicated in the text and
figure legends. Nuclear localization of the polyamides was verified
by deconvolution microscopy, as described (35).
Real-Time qRT-PCR. Real-time qRT-PCR analysis was performed
essentially as described in ref. 45, by using the following primers
for the frataxin gene: 5-CAGAGGAAACGCTGGACTCT-3
and 5-AGCCAGATTTGCTTGTTTGG-3. RNA was stan-
dardized by quantification of GAPDH mRNA (37), and all
values are expressed relative to GAPDH. qRT-PCR was per-
formed by using iScript One-Step RT-PCR kit with SYBR green
(Bio-Rad). Statistical analysis was performed on three indepen-
dent qRT-PCR experiments for each RNA sample, and triplicate
cell incubations were performed.
Western Blot Analysis. Total-cell extracts were used for SDSPAGE
and Western blotting with antibodies to human frataxin (Chemi-
con) or actin (Santa Cruz Biotechnology) as a control for cell
number and protein loading. Signals were detected by chemilumi-
nescence after probing the blot with HRP-conjugated secondary
antibody (Supersignal West; Pierce). To quantify the relative levels
of proteins, autoradiograms (within the linear response range of
x-ray film) were converted into digital images and the signals
quantified by using Molecular Dynamics ImageQuant software.
Fig. 5. Effect of polyamide binding to plasmid DNA on sticky-DNA stability.
(A) Illustration showing the assay for influence of polyamides on sticky-DNA
conformation. (B) The capacity of a polyamide to disrupt the DNADNA-
associated region in the sticky-DNA structure was revealed by the formation
of linearized pRW4886 rather than the EcoNI-cleaved sticky DNA, which
showed the absence of a perturbing influence of the ligands. The polyamides
that had higher Kd values required higher concentrations to observe the
disruption of the DNADNA-associated region of sticky DNA. The polyamides
used were FA1 (green), FA2 (blue), FA3 (black), and FA4 (red).
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DNA Microarrays. FRDA and control lymphoid cells were incu-
bated with polyamides FA1 (at 1 or 2 M) or FA2 (at 2 M),
or in the absence of polyamide, in triplicate for 7 days before
RNA purification and microarray analysis at the California
Institute of Technology microarray facility. Affymetrix U133A
Plus 2.0 GeneChips were hybridized in groups of eight for each
of the three replicates. Raw GeneChip data were normalized
with RMAExpress (38), and the normalized data were filtered
to remove probe sets called absent on 24 of 24 chips from class
comparisons. TheAffymetrix probe set-level data were imported
to BRB Arraytools (Version 3.3.0 Beta 3a), selecting the U133
chips used in the experiment and leaving all filters off. For class
comparisons between groups of arrays, unpaired samples were
used, and the random variance model was selected, with the
univariate significance threshold set to 0.005. The restrictions for
the univariate test were maintained as the default values of 10 for
the maximum number of false discovered genes, 0.1 for the
maximum proportion of false discoveries, and a 90% confidence
level. Because of poor data correlation in one set of replicates,
class comparisons were performed by using all chips for the
control group versus two of the three replicates for the treatment
group (five groups are the minimum number required for class
comparisons). Microarray data (accession no. GSE5040) have
been deposited at Gene Expression Omnibus.
Effects of Polyamides on Sticky DNA. Plasmid pRW4886, which
contains two tracts of (GAATTC)176 in a direct repeat orientation
(10) and forms sticky DNA (13), was treated with polyamides at
concentrations of 0–50 M at 37°C for 1 h. Restriction digestion
with EcoNI after the polyamide incubation enabled visualization of
the presence or absence of anEcoNI-cleaved sticky-DNAband that
runs with decreased mobility compared with the linearized plasmid
on 1%agarose gels (13).Quantitationwas by densitometric analysis
using FluorChem (Version 3.04; Alpha Innotech).
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